Browsing by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 27621 to 27640 of 63193

This table browses all dspace content
Issue DateTitleJournal Title
2007Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinibJOURNAL OF CLINICAL ONCOLOGY
2006Phase II study of gemcitabine and cisplatin in advanced biliary tract cancerJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2015Phase II study of gemcitabine and vinorelbine as second- or third-line therapy in patients with primary refractory or platinum-resistant recurrent ovarian and primary peritoneal cancer by the Korean Cancer Study Group (KCSG)_KCSG GY10-10GYNECOLOGIC ONCOLOGY
2003Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer CANCER RESEARCH AND TREATMENT
2010Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancerRADIOTHERAPY AND ONCOLOGY
2011Phase II study of sunitinib as second-line treatment for advanced gastric cancer INVESTIGATIONAL NEW DRUGS
2012Phase II study of the safety and efficacy of temsirolimus in East Asian patients with advanced renal cell carcinomaJAPANESE JOURNAL OF CLINICAL ONCOLOGY
2009Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinomaONCOLOGY
2015Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma.CANCER CHEMOTHERAPY AND PHARMACOLOGY
1999Phase II trial of a novel platinum analog, SKI 2053R, in patients with previously untreated extensive-stage small cell lung cancerAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
2009Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study JOURNAL OF CLINICAL ONCOLOGY
2012Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma. CANCER
2016Phase II trial of dacomitinib in patients with HER2-positive gastric cancerGASTRIC CANCER
2013Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response GUT AND LIVER
2013Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma ANNALS OF ONCOLOGY
2007Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer CANCER
2008Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma.ANTI-CANCER DRUGS
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancerRADIOTHERAPY AND ONCOLOGY
2012Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) studyANNALS OF HEMATOLOGY

Browse

Links